FIM-001

N/A

Report date: 2025/02/18 11:52:57
NME

Base Information

Drug NameFIM-001
Drug Alias NameFIM-001
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of Actioninterleukin 1 receptor associated kinase 3 degraders
Targetsinterleukin 1 receptor associated kinase 3
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFIMECS Inc
China Registration ClassN/A

Develop Information

Active CompaniesFIMECS Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A